Cas No.: | 2100864-57-9 |
Chemical Name: | 3-Methoxybenzo[b][1,6]naphthyridine-4-carbonitrile |
Synonyms: | CCB02;CCB 02;3-Methoxybenzo[b][1,6]naphthyridine-4-carbonitrile |
SMILES: | O(C([H])([H])[H])C1=C(C#N)C2C(C([H])=N1)=C([H])C1=C([H])C([H])=C([H])C([H])=C1N=2 |
Formula: | C14H9N3O |
M.Wt: | 235.2408 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | CCB02 (CCB 02) is a specific small molecule inhibitor of CPAP-tubulin interaction with IC50 of 0.689 uM in AlphaScreen assay, selectively binds at the CPAP binding site of tubulin; does not inhibits a panel of cell cycle- and centrosome-related kinases; impairs proliferation of cells with centrosome amplification, activates extra centrosomes to nucleate enhanced numbers of microtubules prior to mitosis, causes cells to undergo centrosome de-clustering, prolonged multipolar mitosis, and cell death; demonstrates broad anti-invasive activity in various cancer models, including tyrosine kinase inhibitor (TKI)-resistant EGFR-mutant NSCLC. |